New! Sign up for our free email newsletter.
Science News
from research organizations

A common pathway in the brain that enables addictive drugs to hijack natural reward processing

Date:
April 18, 2024
Source:
The Mount Sinai Hospital / Mount Sinai School of Medicine
Summary:
Researchers have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems.
Share:
FULL STORY

Mount Sinai researchers, in collaboration with scientists at The Rockefeller University, have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems. Published online in Science on April 18, these findings shed new light on the neural underpinnings of drug addiction and could offer new mechanistic insights to inform basic research, clinical practice, and potential therapeutic solutions.

"While this field has been explored for decades, our study is the first to demonstrate that psychostimulants and opioidsengage and alter functioning of the same brain cells that are responsible for processing natural rewards," explains senior author Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic Affairs of the Icahn School of Medicine at Mount Sinai, and Chief Scientific Officer of the Mount Sinai Health System. "These findings provide an explanation for how these drugs can interfere with normal brain function and how that interference becomes magnified with increasing drug exposure to ultimately redirect behavior compulsively towards drugs -- a hallmark of addiction pathology."

The study focused on identifying convergent mechanisms of addiction in mouse models across two different classes of drugs: cocaine, a psychostimulant, and morphine, an opioid. This groundbreaking work required the amalgamation of a highly interdisciplinary team, organized by Dr. Nestler and long-time collaborator Jeffrey M. Friedman, MD, PhD, Marilyn M. Simpson Professor at The Rockefeller University, Investigator of the Howard Hughes Medical Institute, and co-senior author of the study. Among its members were two biophysicists: Alipasha Vaziri, PhD, Professor of Neuroscience and Behavior at The Rockefeller University and a co-senior author of the study, and Tobias Nöbauer, PhD, Assistant Research Professor at The Rockefeller University and a co-first author of the study. Working closely together, the team employed a suite of cutting-edge tools and methodologies spanning behavioral, circuit, cellular, and molecular domains of neuroscience.

Through these innovative efforts, researchers were able to track how individual neurons in a forebrain region called the nucleus accumbens respond to natural rewards like food and water, as well as to acute and repeated exposure to cocaine and morphine in a cell-type-specific manner. They discovered a largely overlapping population of cells that respond to both addictive drugs and natural rewards, and demonstrated that repeated exposure to the drugs progressively disrupts the cells' ability to function normally, resulting in behavior being directed toward drug-seeking and away from natural rewards.

"By tracking these cells, we show that not only are similar cells activated across reward classes, but also that cocaine and morphine elicit initially stronger responses than food or water, and this actually magnifies with increasing exposure," notes co-first author Caleb Browne, PhD, a former Instructor in Dr. Nestler's lab who is now a Scientist in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH) in Toronto. "After withdrawal from the drugs, these same cells exhibit disorganized responses to natural rewards in a manner that may resemble some of the negative affective states seen in withdrawal in substance use disorder."

Moreover, the research team identified a well-established intracellular signaling pathway -- mTORC1 -- that facilitates the disruption of natural reward processing by the drugs. As part of that discovery, investigators found a gene (Rheb) that encodes an activator of the mTORC1 pathway that may mediate this relationship, potentially providing a novel therapeutic target for future discovery in a field of medicine that currently offers few effective treatments.

To that end, the research team plans to dig deeper into the cellular biology behind addiction neuroscience to better characterize molecular pathways that could be critical to basic research and, eventually, clinical practice.

"Through our work we have also established a landmark dataset that integrates drug-induced brain-wide neural activation with input circuit mapping from the nucleus accumbens, which could be useful to the broad scientific community conducting substance use disorder research," says Bowen Tan, the other co-first author of the study, and a graduate student in the laboratory of Dr. Friedman.

"We've known for decades that natural rewards, like food, and addictive drugs can activate the same brain region," says Dr. Friedman. "But what we've just learned is that they impact neural activity in strikingly different ways. One of the big takeways here is that addictive drugs have pathologic effects on these neural pathways, that are distinct from, say, the physiologic response to eating a meal when you are hungry or drinking a glass of water when you are thirsty."

"A major part of our ongoing research will be directed to defining how the flow of multimodal information is incorporated into value computations in brain cells and how that crucial mechanism enables drugs to overtake the processing of natural rewards, leading to addiction," says Dr. Nestler.


Story Source:

Materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Content may be edited for style and length.


Journal Reference:

  1. Bowen Tan, Caleb J. Browne, Tobias Nöbauer, Alipasha Vaziri, Jeffrey M. Friedman, Eric J. Nestler. Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need. Science, 2024; 384 (6693) DOI: 10.1126/science.adk6742

Cite This Page:

The Mount Sinai Hospital / Mount Sinai School of Medicine. "A common pathway in the brain that enables addictive drugs to hijack natural reward processing." ScienceDaily. ScienceDaily, 18 April 2024. <www.sciencedaily.com/releases/2024/04/240418165147.htm>.
The Mount Sinai Hospital / Mount Sinai School of Medicine. (2024, April 18). A common pathway in the brain that enables addictive drugs to hijack natural reward processing. ScienceDaily. Retrieved May 24, 2024 from www.sciencedaily.com/releases/2024/04/240418165147.htm
The Mount Sinai Hospital / Mount Sinai School of Medicine. "A common pathway in the brain that enables addictive drugs to hijack natural reward processing." ScienceDaily. www.sciencedaily.com/releases/2024/04/240418165147.htm (accessed May 24, 2024).

Explore More

from ScienceDaily

RELATED STORIES